Results

Total Results: over 10,000 records

Showing results for "drugs".

5841. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
      January 01, 2024 - Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults Making Healthcare Safer IV Reducing Adverse Drug Events Related to Anticoagulant Use in Adults Rapid Response Main Points 1. Anticoagulation medications help prevent life-threatening events such…

5842. Medication Management | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/reports/engage/interventions/medmanage-slides.html
      May 01, 2017 - Medication Management Patient and Family Engagement in Primary Care Slide 1: Medication Management AHRQ Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families Slide 2: Speaker Kelly Smith, PhD Scientific Director, Quality & Safety Co-PI, AHRQ Guide to Improve …

5843. Facts and Figures Exhibit 5.12
      hcup-us.ahrq.gov/reports/factsandfigures/2008/exhibit5_12.jsp
      January 01, 2008 - Facts and Figures Exhibit 5.12 An official website of the Department of Health & Human Services Search All AHRQ Websites Careers Contact Us Espanol FAQs Email Updates …

5844. Facts and Figures Exhibit 3.3
      hcup-us.ahrq.gov/reports/factsandfigures/2007/exhibit3_3.jsp
      January 01, 2007 - Facts and Figures Exhibit 3.3 An official website of the Department of Health & Human Services Search All AHRQ Websites Careers Contact Us Espanol FAQs Email Updates …

5845. Questions and Answers About the CAHPS Cancer Care Survey (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/questions-and-answers-about-cancer-care-survey.pdf
      June 02, 2025 - Questions and Answers About the CAHPS Cancer Care Survey 1 Questions and Answers About the CAHPS® Cancer Care Survey Q: Why are there three versions of the CAHPS Cancer Care Survey, and do I need to field them all? A: The three versions of the Cancer Care Survey reflect the three most common treatment modalities…

5846. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
      January 31, 2013 - can be drawn about the benefits of ACE inhibitors and statins, we will not include studies of these drugs … Administration FDA Status Indications/Warnings Plavix Clopidogrel Bristol Myers Squibb Sanofi Pharmaceuticals

5847. Improving Laboratory Monitoring in Community Practices: A Randomized Trial - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r18hs017201-simon-final-report-2012.pdf
      January 01, 2012 - Improving Laboratory Monitoring in Community Practices: A Randomized Trial - Final Report AHRQ Final Report Improving Laboratory Monitoring in Community Practices: A Randomized Trial P…

5848. CER 217 Management of Infertility Evidence Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
      May 01, 2019 - use of ovulation-induction agents including oral (clomiphene citrate or letrozole) and injected drugs … Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. … Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. … Effects of fertility drugs on cancers other than breast and gynecologic malignancies. … Long-term relationship of ovulation-stimulating drugs to breast cancer risk.

5849. Screening and Behavioral Counseling Interventions to Reduce Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/m_E9nFrmxuS5-surqVHK2u
      November 13, 2018 - J Stud Alcohol Drugs. 2014;75(1):153-157. doi:10 .15288/jsad.2014.75.153 65. … J Stud Alcohol Drugs. 2014;75(6):982-992. doi:10.15288/jsad.2014.75.982 80. … J Stud Alcohol Drugs. 2014;75(3):447-457. doi:10.15288/jsad.2014.75.447 87. … J Stud Alcohol Drugs. 2010;71(1):23-31. doi:10.15288/jsad.2010.71.23 88. … J Stud Alcohol Drugs. 2009;70(4):555-567. doi:10 .15288/jsad.2009.70.555 130.

5850. Tragic error with neuromuscular blocker should prompt risk assessment by all hospitals. | PSNet
      psnet.ahrq.gov/issue/tragic-error-neuromuscular-blocker-should-prompt-risk-assessment-all-hospitals
      November 16, 2015 - November 5, 2014 A mislabeling event with batched drugs: the unintended consequences … Departments Health Care Providers Emergency Medicine Hospital Pharmacy Specific to High-Risk Drugs

5851. Urinary-Incontinence-Treatment Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
      September 30, 2010 - Adverse events resulting from drugs. 2. … Adrenergic drugs for urinary incontinence in adults. … Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. … Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. … delirium/confusional state; urinary tract infection (symptomatic); atrophic urethritis/vaginitis; use of pharmaceuticals

5852. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/5W2k4HLBPLPgHov6sSvuMH
      July 24, 2018 - Government of Canada website. https://www.canada.ca/en/public-health/ services/publications/drugs-health-products … dx.doi.org/10.1056/NEJM198903233201204 https://www.canada.ca/en/public-health/services/publications/drugs-health-products … national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2015.html https://www.canada.ca/en/public-health/services/publications/drugs-health-products … national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2015.html https://www.canada.ca/en/public-health/services/publications/drugs-health-products … national-surveillance-antimicrobial-susceptibilities-neisseria-gonorrhoeae-annual-summary-2015.html https://www.canada.ca/en/public-health/services/publications/drugs-health-products

5853. Osteoporosis-Bone-Fracture Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
      March 01, 2012 - Pharmacologic agents include the bisphosphonate class of drugs, peptide hormones (parathyroid hormone … that had been rejected on the basis of drugs that were now included within the scope of the update … indicated for the treatment of osteoporosis (but not if the drugs were being used to treat cancer); … , and single drug versus single drug comparisons for drugs within the same class and across classes … • How was exposure to drugs/exercise ascertained?

5854. Medication safety issue brief. Bar code implementation strategies. | PSNet
      psnet.ahrq.gov/issue/medication-safety-issue-brief-bar-code-implementation-strategies
      June 17, 2014 - Look-alike, sound-alike drugs. … December 12, 2012 Impact of interactions between drugs and laboratory test results on

5855. Recommendations for practitioners and manufacturers to address system-based causes of vaccine errors. | PSNet
      psnet.ahrq.gov/issue/recommendations-practitioners-and-manufacturers-address-system-based-causes-vaccine-errors
      June 18, 2014 - June 4, 2014 Audit of missed or delayed antimicrobial drugs. … December 15, 2010 Cardiovascular drugs: linked to many errors.

5856. Metric units and the preferred dosing of orally administered liquid medications. | PSNet
      psnet.ahrq.gov/issue/metric-units-and-preferred-dosing-orally-administered-liquid-medications
      April 11, 2011 - Copy URL July 3, 2016 Neville K, Galinkin JL, Green TP, et al; Committee on Drugs … January 11, 2017 Key potentially inappropriate drugs in pediatrics: the KIDs list.

5857. Unverified patient-reported error: a false alarm can have real consequences. | PSNet
      psnet.ahrq.gov/issue/unverified-patient-reported-error-false-alarm-can-have-real-consequences
      June 05, 2018 - May 7, 2014 A mislabeling event with batched drugs: the unintended consequences of practice … February 19, 2014 Survey suggests possible downward trend in identifying key drugs/drug

5858. Sponsored Health IT and Evidence-Based Prescribing among Medical Residents - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs022927-primack-final-report-2017.pdf
      January 01, 2017 - non-EBP) in the United States are multifaceted, the multi-billion-dollar marketing of prescription drugs … Drugs: safe use initative fact sheet. … United States, 2014. http://www.fda.gov/Drugs/DrugSafety/ucm188760.htm. … A decade of direct-to-consumer advertising of prescription drugs. … Direct-to-consumer advertising of pharmaceuticals. Am J Med 2007; 120: 475–80.

5859. Novel Drug Misuse | PSNet
      psnet.ahrq.gov/web-mm/novel-drug-misuse
      September 30, 2010 - that the commentary does not include information about or discuss investigational or off-label use of pharmaceutical … products or medical devices. … addition, the commentary does not include information regarding investigational or off-label use of pharmaceutical … products or medical devices. … July 14, 2010 Adverse events associated with sedatives, analgesics, and other drugs that

5860. Enhanced Medication Histories (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
      October 01, 2011 - Reminder rates for elderly patients taking at least two drugs from the list of “Drugs to Avoid in … But as may be seen from Table 20 and 21, drugs from the HEDIS list of “Drugs to Avoid in the Elderly … Reminder rates for elderly patients taking at least two drugs from the list of “Drugs to Avoid in the … most frequent Drugs to Avoid in the Elderly. … Drugs To Be Avoided in the Elderly Category 5.